NEW-ONSET INFLAMMATORY BOWEL DISEASE DURING TREATMENT WITH THE ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY SECUKINUMAB. A CASE SERIES PRESENTATION

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing